ClinicalTrials.govpublic full text
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
carcinoma, hepatocellular, hepatocellular carcinoma, sorafenib, adjuvant, surgical resection, ablation, nexavar, adjuvant therapy, liver cancer, hcc, storm, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865996
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.